Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography

Bone Marrow ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

Response To Treatment ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Monitoring Response ◽

Commentary on “Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography”

Clinical Lymphoma ◽

10.1016/s1526-9655(11)70178-6 ◽

2001 ◽

Vol 1 (4) ◽

pp. 307

Author(s):

Lale Kostakoglu

Keyword(s):

Bone Marrow ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

Response To Treatment ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Monitoring Response ◽

Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy

Indian Journal of Nuclear Medicine ◽

10.4103/0972-3919.119545 ◽

2013 ◽

Vol 28 (3) ◽

pp. 178 ◽

Cited By ~ 5

Author(s):

Rakesh Kumar ◽

VarunSingh Dhull ◽

Sachin Jain ◽

Chandrasekhar Bal ◽

Punit Sharma ◽

...

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Bone Metastases ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Monitoring Response ◽

Frequent Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography on the Staging and Management of Patients with Indolent Non-Hodgkin's Lymphoma

Clinical Lymphoma ◽

10.3816/clm.2003.n.013 ◽

2003 ◽

Vol 4 (1) ◽

pp. 43-49 ◽

Cited By ~ 60

Author(s):

Robert H. Blum ◽

John F. Seymour ◽

Andrew Wirth ◽

Michael MacManus ◽

Rodney J. Hicks

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Non Hodgkin’S Lymphoma ◽

Positron Emission ◽

Non Hodgkin's Lymphoma ◽

Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group

Hematology Transfusion and Cell Therapy ◽

10.1016/j.htct.2018.03.002 ◽

2018 ◽

Vol 40 (3) ◽

pp. 245-249

Author(s):

Juliano Júlio Cerci ◽

Mateos Bogoni ◽

Valeria Buccheri ◽

Elba Cristina Sá de Camargo Etchebehere ◽

Talita Maira Bueno da Silveira ◽

...

Keyword(s):

Bone Marrow ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

Study Group ◽

Positron Emission ◽

Lymphoma Study Group ◽

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography

Haematologica ◽

10.3324/haematol.10591 ◽

2008 ◽

Vol 93 (3) ◽

pp. 390-397 ◽

Cited By ~ 29

Author(s):

C. Bodet-Milin ◽

F. Kraeber-Bodere ◽

B. Dupas ◽

F. Morschhauser ◽

T. Gastinne ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Non Hodgkin’S Lymphoma ◽

Positron Emission ◽

Non Hodgkin's Lymphoma ◽

Mycobacterial lymphadenitis in a human immunodeficiency virus-infected patient: Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring the response to treatment

Indian Journal of Nuclear Medicine ◽

10.4103/ijnm.ijnm_125_19 ◽

2019 ◽

Vol 34 (4) ◽

pp. 329

Author(s):

Luca Filippi ◽

Barbara Sardella ◽

Orazio Schillaci ◽

Oreste Bagni

Keyword(s):

Human Immunodeficiency Virus ◽

Infected Patient ◽

Emission Tomography ◽

Response To Treatment ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Immunodeficiency Virus ◽

Decreased Bone Marrow Activity Measured by Using 18F-fluorodeoxyglucose Positron Emission Tomography among Patients with Cerebral Atherosclerosis

Journal of Neurosonology and Neuroimaging ◽

10.31728/jnn.2018.00028 ◽

2019 ◽

Vol 11 (1) ◽

pp. 78-83 ◽

Cited By ~ 1

Author(s):

Jeong-Min Kim ◽

Eun Seong Lee ◽

Kwang-Yeol Park ◽

Ju Won Seok ◽

Oh-Sang Kwon

Keyword(s):

Bone Marrow ◽

Emission Tomography ◽

Cerebral Atherosclerosis ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Marrow Activity ◽

Value of [18F]Fluorodeoxyglucose–Positron Emission Tomography in Managing Adults with Aggressive Non-Hodgkin's Lymphoma

Clinical Lymphoma & Myeloma ◽

10.3816/clm.2006.n.005 ◽

2006 ◽

Vol 6 (4) ◽

pp. 306-313 ◽

Cited By ~ 19

Author(s):

Michel Meignan ◽

Corinne Haioun ◽

Emmanuel Itti ◽

Alain Rahmouni ◽

Felix Reyes

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Non Hodgkin’S Lymphoma ◽

Positron Emission ◽

Non Hodgkin's Lymphoma ◽

Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin’s lymphoma

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000001120 ◽

2020 ◽

Vol 41 (1) ◽

pp. 26-33

Author(s):

Takayoshi Shinya ◽

Yoichi Otomi ◽

Antonia Dimitrakopoulou-Strauss ◽

Michiko Kubo ◽

Mihoko Kondo ◽

...

Keyword(s):

Computed Tomography ◽

Clinical Assessment ◽

Hodgkin's Lymphoma ◽

Emission Tomography ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Non Hodgkin's Lymphoma ◽

18F‐Fluorodeoxyglucose Positron Emission Tomography for Monitoring Response to Sorafenib Treatment in Patients with Hepatocellular Carcinoma

The Oncologist ◽

10.1634/theoncologist.2008-0063 ◽

2008 ◽

Vol 13 (6) ◽

pp. 734-735 ◽

Cited By ~ 11

Author(s):

Ester J. M. Siemerink ◽

Nanno H. Mulder ◽

Adrienne H. Brouwers ◽

Geke A. P. Hospers

Keyword(s):

Hepatocellular Carcinoma ◽

Emission Tomography ◽

Sorafenib Treatment ◽

18F Fluorodeoxyglucose ◽

Positron Emission ◽

Monitoring Response ◽